Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Exclusive Article Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025Submitted by Leo Miller. Published: 1/3/2026. 
Key Takeaways - While small caps as a whole generated lower returns than large caps in 2025, three interesting names bucked this narrative.
- A cancer screening company and two satellite operators saw their shares rise 300% or more.
- See where analysts are forecasting upside and understand vital considerations pertaining to smaller stocks.
In 2025, small-cap stocks lagged. The Russell 2000, which tracks 2,000 U.S. small-cap companies, returned about 13% for the year — notably below the S&P 500's roughly 18% total return. Despite the broader underperformance, three small-cap names delivered exceptional returns in 2025. Below, we highlight three stocks that rose 300% or more. Each began the year in small-cap territory but, after their gains, has moved into mid-cap range. GRAL Catapults on Early Cancer Detection Enthusiasm This isn't a boom where everyone wins. It's a transfer from one group to another—like railroads (1800s) and internet (1990s). Louis Navellier, who spent 46 yrs on Wall St., built the grading system institutions paid $24,000/yr for him to evaluate stocks with. Now, his system shows exactly where the $7 trillion is flowing. And it's not AI. Click here for the full story. Healthcare stock GRAIL (NASDAQ: GRAL) surged roughly 380% in 2025. Its market capitalization climbed from well under $1 billion to about $3.3 billion. GRAIL's flagship product is the Galleri multi-cancer early detection test. Early detection greatly improves cancer survival rates, which has driven investor interest in Galleri. Only about five cancers have standardized screening methods, yet roughly 70% of cancer deaths come from other types. Galleri is designed to detect more than 50 types of cancer. In a recent study, GRAIL reported that adding Galleri to traditional screening increased early cancer detection by more than sevenfold. Today, most Galleri sales come from out-of-pocket payments. GRAIL plans to apply for premarket approval (PMA) from the U.S. Food and Drug Administration in the first quarter of 2026. If approved, the test would be far more likely to receive commercial insurance coverage, opening a meaningful reimbursement channel and a large new sales opportunity. That potential approval is a major reason for investor enthusiasm. The MarketBeat consensus price target of $97.50 reflects analyst optimism and implies roughly 14% upside from current levels. PL Blasts Off, Combining AI with Geospatial Imagery Planet Labs PBC (NYSE: PL) rallied nearly 390% in 2025. Planet operates hundreds of satellites that capture medium- to high-resolution images of Earth and pairs that imagery with artificial intelligence to help customers make decisions. The company sells subscriptions to its cloud platform and provides satellite services. Demand, particularly from government customers, has been strong. Its Dec. 10 earnings report sent shares up 35% in a single day, driven by defense and intelligence revenue growth of over 70%. Planet reported a backlog of about $735 million — roughly 2.6 times its trailing 12-month revenue of $282 million — providing a runway for meaningful revenue expansion. The company also reported positive free cash flow for the second consecutive quarter. The MarketBeat consensus price target of $14.74 implies about 25% downside from current levels. However, analyst targets updated after the company's latest earnings average $18.19, which would imply roughly 7.7% downside. Planet Labs remains a name to watch; a significant pullback could present a buying opportunity. Updated Targets Eye Strong Upside in VSAT After Huge 2025 Run Last is Viasat (NASDAQ: VSAT), which gained roughly 305% in 2025 and now has a market cap around $4.7 billion. Like Planet, Viasat is a satellite company, but it focuses on internet and data connectivity for aviation, maritime and government customers rather than primarily serving consumer telecom operators. It can be compared to names such as AST SpaceMobile (NASDAQ: ASTS) in certain respects. Viasat provides in-flight connectivity to thousands of commercial and business aircraft. The U.S. government was its largest customer in fiscal 2025, accounting for 18% of revenue. (Viasat is currently in fiscal 2026.) Revenues grew by just 2% in the most recent quarter, but awards increased 17% to nearly $1.5 billion and backlog rose to almost $3.9 billion. The MarketBeat consensus price target of $32.75 suggests about 5% downside. However, analyst targets updated after the Nov. 7 earnings report average $49, implying roughly 37% upside potential. GRAL, PL, VSAT: Deep Research Is Paramount GRAL, PL and VSAT delivered spectacular returns in 2025, but investors should remember that smaller, fast-rising stocks can be highly volatile. Significant price swings are common, so having a well-founded, long-term thesis is essential. Perform thorough due diligence and consider how each company fits into your risk tolerance and portfolio goals before making investment decisions.
| 
